EUVIMEDEUVIMED entdecken
Crossref

Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data

Steven Platko, Fatima Bensabeur, David Peters, Noor Darwich, Nicholas Rotsching, Jacob Wagner, Umran Ugur, Shelly Reynolds, John B Terry, Esteban Cheng-Ching

Journal of Clinical Neuroscience · 2024

DOI: 10.1016/j.jocn.2024.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Neuroscience, 2024. Verfasst von Steven Platko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States; Clinical Neuroscience Institute, Premier He…. Hauptthemen laut MEDLINE: Tenecteplase, Fibrinolytic Agents, Ischemic Stroke, Thrombectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We sought to describe short term outcomes in patients with large vessel occlusion acute ischemic stroke (LVOAIS) who were treated with intravenous tenecteplase (TNK) as compared to alteplase (tPA), focusing on reduction in the need for mechanical thrombectomy (MT). BACKGROUND: In LVOAIS, TNK has shown improved reperfusion and outcomes with a similar safety profile to tPA. Ultra-early reperfusion has been described with TNK which would prevent the need for MT. We analyze the magnitude of this effect in a "real-world" setting. DESIGN/METHODS: In this retrospective study, demographic, clinical, and imaging information from patients with LVOAIS treated with intravenous thrombolysis was collected. Data was compared between the group treated with TNK and tPA. RESULTS: One hundred eighty-six patients met the criteria for the study. Of these,144patients received tPA and 42 received TNK. Nine had clinical improvement prior to groin puncture and did not require angiography. When combining the number of patients who had recanalization on angiography before MT and those who had clinical improvement prior to angiography, there were a total of 23 patients. This was noted in 9.7 % of patients who received tPA and 21.4 % of those who received TNK (p = 0.043). For patients treated with TNK we observed a rapid clinical improvement, improved NIHSS, improved functional outcomes and decreased length of stay compared to patients treated with tPA. For patients with spontaneous recanalization either angiographically or with clinical improvement from intravenous thrombolysis, MT may not be required. CONCLUSIONS: Intravenous TNK in patients with LVOAIS decreases the need for MT, and is associated with improved outcomes and reduced length of stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenecteplaseFibrinolytic AgentsIschemic StrokeThrombectomyTissue Plasminogen ActivatorHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeAdministration, IntravenousAged, 80 and overThrombolytic Therapy

Stichwörter der Autor:innen

AlteplaceStrokeTenecteplaceThrombolysistPA

Substanzen

TenecteplaseFibrinolytic AgentsTissue Plasminogen Activator

Autor:innen und Institutionen

  • Department of Neurology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States; Clinical Neuroscience Institute, Premier Health, Dayton, OH, United States.
  • Department of Pharmacy, Premier Health Miami Valley Hospital, Dayton, OH, United States; Department of Pharmacy Practice, Cedarville University School of Pharmacy, Cedarville, OH, United States.
  • Clinical Neuroscience Institute, Premier Health, Dayton, OH, United States.
  • Department of Neurology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States.
  • Department of Neurology, Wright State University Boonshoft School of Medicine, Dayton, OH, United States; Clinical Neuroscience Institute, Premier Health, Dayton, OH, United States. Electronic address: echeng@PremierHea…

Zitieren

APA

Platko, S., Bensabeur, F., Peters, D., Darwich, N., Rotsching, N., Wagner, J., Ugur, U., Reynolds, S., Terry, J. B., & Cheng-Ching, E. (2024). Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data. Journal of Clinical Neuroscience. https://doi.org/10.1016/j.jocn.2024.06.005

Vancouver

Platko S, Bensabeur F, Peters D, Darwich N, Rotsching N, Wagner J, et al. Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data. Journal of Clinical Neuroscience. 2024. doi:10.1016/j.jocn.2024.06.005

BibTeX
@article{Platko2024,
  author = {Platko, Steven and Bensabeur, Fatima and Peters, David and Darwich, Noor and Rotsching, Nicholas and Wagner, Jacob and Ugur, Umran and Reynolds, Shelly and Terry, John B and Cheng-Ching, Esteban},
  title = {Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data},
  journal = {Journal of Clinical Neuroscience},
  year = {2024},
  doi = {10.1016/j.jocn.2024.06.005}
}
Kostenlos starten →